How Worried Should Investors Be About CytomX Therapeutics Inc (CTMX)

CytomX Therapeutics Inc (NASDAQ:CTMX) does about 6.38M shares in volume on a normal day but saw 2254714 shares change hands in Monday trading. The company now has a market cap of 127.01M USD. Its current market price is $1.63, marking a decrease of -0.61% compared to the previous close of $1.64. The 52 week high reached by this stock is $5.85 whilst the lowest price level in 52 weeks is $1.04.

CytomX Therapeutics Inc (CTMX) has a 20-day trading average at $1.7980 and the current price is -72.14% off the 52-week high compared with 56.73% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.1624 and its 200-day simple moving average is $1.6970. If we look at the stock’s price movements over the week, volatility stands at 5.91%, which increases to 6.24% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 38.87 to suggest the stock is neutral.

The consensus objective for the share price is $5.32, suggesting that the stock has a potential upside of 69.36% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 28, 2024 when Piper Sandler upgraded the stock to “Overweight” and issued a price target of between $2.25 and $3.50. Wedbush also upgraded the stock to “Outperform” from Neutral on May 09, 2024 at a price target of $8. Jefferies upgraded its price target at $2.50-$8.

CytomX Therapeutics Inc (CTMX) stock is down -6.86% over the week and -20.10% over the past month. Its price is 5.16% year-to-date and -6.32% over the past year.

To reach the target analysts have set, the stock logically needs to grow 69.36 percent from here.

The price to earnings ratio (P/E ratio) amounts to 8.15. The beta has a value of 1.10. Price to sales ratio is 1.07.